Skip to main content

Veru Inc.

VERU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000863894

No open-market purchases or sales by Veru Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q3 2026, worth $6.92M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Veru Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Veru Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Veru Inc.
NameTitleLast reported holdingLast filingFilings, past year
Barnette K GaryChief Scientific Officer2,300Aug 17, 20263
Steiner Mitchell ShusterPresident and CEO6,942,709May 6, 20262
Rankowitz Michael LDirector250,000May 6, 20262
Lu LucyDirector9,800May 6, 20262
Greco MicheleChief Admin Officer and CFO–May 6, 20262
Fisch HarryChief Corporate Officer774,736May 6, 20262
Hyun GraceDirector–May 6, 20262
Katzovitz Loren MarkDirector–May 6, 20262
Eisenberger MarioDirector0Oct 2, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 17, 2026 (view filing)4:26 PM ETAug 134 daysBarnette K GaryChief Scientific OfficerPPurchase+1.80K$2.69+$4.84K+360.0%2.30K after
Feb 20, 2025 (view filing)Feb 18-192 daysRankowitz Michael LDirectorPPurchase+150.0K$0.5609+$84.1K+150.0%250.0K after2 lots
May 28, 2024 (view filing)May 244 daysFisch HarryChief Corporate OfficerPPurchase+4.00K$1.25+$5.00K+0.5%774.7K after
May 24, 2024 (view filing)May 24Same dayBarnette K GaryChief Scientific OfficerPPurchase+5.00K$1.34+$6.70KNew position5.00K after
May 24, 2024 (view filing)May 22-242 daysSteiner Mitchell ShusterPresident and CEOSSale−70.2K$1.25−$87.4K−1.0%6.94M after3 lots
May 17, 2024 (view filing)May 152 daysFisch HarryChief Corporate OfficerPPurchase+6.71K$1.49+$10.0K+0.9%770.7K after
May 17, 2024 (view filing)May 15-172 daysSteiner Mitchell ShusterPresident and CEOSSale−171.9K$1.44−$247.4K−2.4%7.01M after3 lots
Aug 17, 2022 (view filing)Aug 152 daysEisenberger MarioDirectorSSale−100.0K$20.04−$2.00M−100.0%0 after
Aug 19, 2021 (view filing)Aug 172 daysLu LucyDirectorPPurchase+4.80K$6.78+$32.5K+96.0%9.80K after